By Contributing Writer Gina Hagler There are nearly 7,000 rare diseases affecting approximately 1% of the global population. When your child is affected with one of these rare diseases, and...
Learn More
ROCKVILLE, Md., July 30, 2020 (GLOBE NEWSWIRE) — American Gene Technologies (AGT), an internationally recognized advanced gene and cell therapy company in Rockville, MD, today announced a coauthored article by scientists from...
Learn More
ROCKVILLE, Md., July 28, 2020 — American Gene Technologies (AGT), an internationally recognized leading gene and cell therapy company in Rockville, Maryland, today announced it has leased a spacious, modern...
Learn More
The Harvard Business Review (HBR) has provided thought-provoking content since 1922. Whether business leaders are interested in optimizing their organizational structure or instituting programs to retain key employees, the HBR...
Learn More
TED Talks began in 1984 as a conference originating in Silicon Valley where powerful voices in Technology, Entertainment, and Design came together to spread potent ideas with broad relevance. Today...
Learn More
Written by Jeff Galvin, CEO of American Gene Technologies The birth of high-value therapeutics and cures Does the development of effective drugs have to be incredibly expensive? Maybe not anymore. There...
Learn More
Summary: American Gene Technologies is a leader in cell and gene therapy of infectious diseases, monogenic diseases, and cancer. Located in Rockville, Maryland, we are expanding the capacity for Research...
Learn More
Original Article: Molecular Therapy: Methods & Clinical Development Vol. 17 June 2020 Haishan Li,1 Tyler Lahusen,1 Lingzhi Xiao,1 Nidal Muvarak,1 Jana Blazkova,2 Tae-Wook Chun,2 and C. David Pauza1 1American Gene...
Learn More
VOLUME 9 May 2020 Newsletter FDA Progress The Path to the Clinic For the HIV Cure This month, AGT saw tremendous progress with the FDA. FDA time and attention to...
Learn More
(click image to view larger – click here to download) Read The Original Press Release
Learn More
Contributing Author John Vandermosten, Senior Biotechnology Analyst Examining events of the past can give us a sense of what to expect in the periods ahead. And despite the omnipresent warning that...
Learn More
Subscribe to our YouTube Channel “We are at the beginning of the technology curve in pharmaceuticals.” Jeff Galvin, CEO of American Gene Technologies (AGT), explains his ascent into the biotechnology...
Learn More